These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37277571)

  • 1. Comparison of genetic variation between primary colorectal cancer and metastatic peritoneal cancer.
    Shin W; Yun J; Han K; Park DG
    Genes Genomics; 2023 Aug; 45(8):989-1001. PubMed ID: 37277571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic specificity study using next-generation sequencing (NGS) of peritoneal metastatic colorectal cancer compared to primary colorectal cancer.
    Lee S; Shin W; Park DG; Namgung H
    Genes Genomics; 2024 Mar; 46(3):289-302. PubMed ID: 38316717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.
    Heublein S; Albertsmeier M; Pfeifer D; Loehrs L; Bazhin AV; Kirchner T; Werner J; Neumann J; Angele MK
    BMC Cancer; 2018 Feb; 18(1):201. PubMed ID: 29463215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Fujiyoshi K; Yamamoto G; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
    Oncol Rep; 2017 Feb; 37(2):785-792. PubMed ID: 28000889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer: Metastases to a single organ.
    Vatandoust S; Price TJ; Karapetis CS
    World J Gastroenterol; 2015 Nov; 21(41):11767-76. PubMed ID: 26557001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic biomarkers for metastatic colorectal cancer].
    Neumann JH
    Pathologe; 2016 Nov; 37(Suppl 2):180-185. PubMed ID: 27638531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis of Somatic Mutations in Colorectal Cancer With Peritoneal Metastasis.
    Lee JH; Ahn BK; Baik SS; Lee KH
    In Vivo; 2019; 33(2):447-452. PubMed ID: 30804124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Mutation Profiling of Colorectal Cancer Patients With Lung or Liver Metastasis by Targeted Next-Generation Sequencing.
    Hu CT; Wang JL; Hou T; Yan ZW; Zu LD; Fu GH; Shen WW
    Technol Cancer Res Treat; 2023; 22():15330338231185285. PubMed ID: 37394872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Staging System for Colorectal Cancer Patients with Synchronous Peritoneal Metastasis in Accordance with the Japanese Classification of Colorectal Carcinoma: A Multi-Institutional Study.
    Noura S; Ohue M; Ito Y; Miyoshi N; Kobayashi H; Kotake K; Sugihara K
    Dig Surg; 2016; 33(1):66-73. PubMed ID: 26618448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
    Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A
    Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.
    Thomassen I; van Gestel YR; Lemmens VE; de Hingh IH
    Dis Colon Rectum; 2013 Dec; 56(12):1373-80. PubMed ID: 24201391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.
    Franko J; Shi Q; Meyers JP; Maughan TS; Adams RA; Seymour MT; Saltz L; Punt CJA; Koopman M; Tournigand C; Tebbutt NC; Diaz-Rubio E; Souglakos J; Falcone A; Chibaudel B; Heinemann V; Moen J; De Gramont A; Sargent DJ; Grothey A;
    Lancet Oncol; 2016 Dec; 17(12):1709-1719. PubMed ID: 27743922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer.
    Schrock AB; Ouyang C; Sandhu J; Sokol E; Jin D; Ross JS; Miller VA; Lim D; Amanam I; Chao J; Catenacci D; Cho M; Braiteh F; Klempner SJ; Ali SM; Fakih M
    Ann Oncol; 2019 Jul; 30(7):1096-1103. PubMed ID: 31038663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose-derived stem cells promote glycolysis and peritoneal metastasis via TGF-β1/SMAD3/ANGPTL4 axis in colorectal cancer.
    Zhu C; Teng L; Lai Y; Yao X; Fang Y; Wang Z; Lin S; Zhang H; Li Q; Li Y; Cai J; Zhang Y; Wu C; Huang B; Li A; Liu S; Lai Q
    Cell Mol Life Sci; 2024 Apr; 81(1):189. PubMed ID: 38643448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of colorectal cancer related peritoneal metastatic disease.
    Lenos KJ; Bach S; Ferreira Moreno L; Ten Hoorn S; Sluiter NR; Bootsma S; Vieira Braga FA; Nijman LE; van den Bosch T; Miedema DM; van Dijk E; Ylstra B; Kulicke R; Davis FP; Stransky N; Smolen GA; Coebergh van den Braak RRJ; IJzermans JNM; Martens JWM; Hallam S; Beggs AD; Kops GJPL; Lansu N; Bastiaenen VP; Klaver CEL; Lecca MC; El Makrini K; Elbers CC; Dings MPG; van Noesel CJM; Kranenburg O; Medema JP; Koster J; Koens L; Punt CJA; Tanis PJ; de Hingh IH; Bijlsma MF; Tuynman JB; Vermeulen L
    Nat Commun; 2022 Aug; 13(1):4443. PubMed ID: 35927254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.
    de Cuba EM; Kwakman R; Knol DL; Bonjer HJ; Meijer GA; Te Velde EA
    Cancer Treat Rev; 2013 Jun; 39(4):321-7. PubMed ID: 23244778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites.
    El-Deiry WS; Vijayvergia N; Xiu J; Scicchitano A; Lim B; Yee NS; Harvey HA; Gatalica Z; Reddy S
    Cancer Biol Ther; 2015; 16(12):1726-37. PubMed ID: 26553611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer.
    Jesinghaus M; Wolf T; Pfarr N; Muckenhuber A; Ahadova A; Warth A; Goeppert B; Sers C; Kloor M; Endris V; Stenzinger A; Weichert W
    Am J Surg Pathol; 2015 Aug; 39(8):1140-7. PubMed ID: 25786087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
    Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
    Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for brain metastases in patients with metastatic colorectal cancer.
    Christensen TD; Palshof JA; Larsen FO; Høgdall E; Poulsen TS; Pfeiffer P; Jensen BV; Yilmaz MK; Christensen IJ; Nielsen D
    Acta Oncol; 2017 May; 56(5):639-645. PubMed ID: 28447565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.